Table 1.
Radiogenomic studies published in the literature
| Study | Year | Country | Data source | Number | Validation set | Cancer | Imaging modality | Number of features | Method of feature extraction | Radiologist involvement | Genomic data | Individual vs clusters | Pathway analysis | Wet-lab validation | Histology correlation | Outcome | Clinical outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gevaert et al15 | 2012 | USA | Single institutional | 26 | No | NSCLC | PET | 180 | Both | Yes | Microarray | Clusters | Yes | No | No | Yes | RFS and OS |
| Gevaert et al16 | 2014 | USA | TCGA | 55 | No | GBM | MR | 79 | Manual | Yes | Microarray, DNA methylation, array CGH | Clusters | Yes | No | No | Yes | PFS and OS |
| Aerts et al9 | 2014 | Netherlands | Multi-institutional | 89 | No | NSCLC | CT | 440 | Semi-automated | No | Microarrays | Clusters | Yes | No | Yes | Yes | OS |
| Jamshidi et al17 | 2014 | USA | Single institutional | 23 | No | GBM | MR | 6 | Manual | Yes | Microarrays, array CGH | Clusters | Yes | No | No | No | NA |
| Kuo et al18 | 2007 | USA | Single institutional | 30 | No | HCC | CT | 6 | Manual | Yes | Microarrays | Clusters | No | No | Yes | No | NA |
| Nair et al19 | 2012 | USA | Multi-institutional | 25 | No | NSCLC | PET | 14 | Semi-automated | Yes | Microarrays | Both | Yes | No | No | Yes | OS |
| Segal et al20 | 2007 | USA | Single institutional | 28 | Yes | HCC | CT | 138 | Manual | Yes | Microarrays | Clusters | Yes | No | Yes | Yes | OS |
| Yamamoto et al21 | 2012 | USA | Single institutional | 10 | No | Breast cancer | MR | 26 | Manual | Yes | Microarrays | Both | Yes | No | No | No | NA |
| Yamamoto et al22 | 2015 | USA | Single institutional | 19 | Yes | Breast cancer | MR | 47 | Semi-automated | Yes | RNA sequencing | Individual | Yes | Yes | Yes | Yes | MFS |
| Zinn et al23 | 2011 | USA | TCGA | 26 | Yes | GBM | MR | 3 | Semi-automated | Yes | mRNA and micro-RNA | Individual | Yes | No | No | Yes | PFS and OS |
| Barajas et al24 | 2010 | USA | Single institutional | 12 | No | GBM | MR | 9 | Manual | Yes | Microarray | Both | Yes | No | Yes | No | NA |
| Diehn et al25 | 2008 | USA | Single institutional | 22 | No | GBM | MR | 10 | Manual | Yes | Microarray | Both | Yes | Yes | No | Yes | OS |
| Pope et al26 | 2008 | USA | Single institutional | 52 | No | GBM | MR | 1 | Manual | Yes | Microarray | Individual | No | Yes | Yes | Yes | OS |
| Zinn et al27 | 2012 | USA | TCGA | 78 | Yes | GBM | MR | 1 | Manual | NA | Microarray and micro-RNA | Individual | Yes | No | No | Yes | OS |
| Jamshidi et al28 | 2015 | USA | Single institutional | 70 | Yes | CCRCC | CT | 35 | Manual | Yes | Microarray | Both | No | No | No | Yes | OS |
| Colen et al29 | 2014 | USA | TCGA | 99 | No | GBM | MRI | 1 | Manual | Yes | Microarray and micro-RNA | Individual | Yes | No | Yes | Yes | OS |
| Carlson et al30 | 2007 | USA | Single institutional | 71 | No | HGG | MRI | 1 | Manual | NA | Microarray | Individual | No | No | No | Yes | OS |
| Colen et al31 | 2014 | USA | TCGA | 104 | No | GBM | MRI | 30 | Manual | Yes | Microarray | Both | Yes | No | No | Yes | OS |
| Jain et al32 | 2012 | USA | TCGA | 18 | No | GBM | CT | 2 | Manual | Yes | Microarray | Individual | Yes | No | No | No | NA |
| Naeini et al33 | 2013 | USA | Single institutional | 46 | No | GBM | MRI | 3 | Manual | NA | Microarray | Clusters | Yes | No | No | Yes | OS |
| Nicolasjilwan et al34 | 2015 | USA | TCGA | 68 | Yes | GBM | MRI | 30 | Manual | NA | Microarrays, array CGH | Clusters | Yes | No | No | No | NA |
| Pope et al35 | 2012 | USA | Single institutional | 38 | No | GBM | MRI | 1 | Manual | Yes | Microarray | Individual | Yes | No | Yes | Yes | OS |
| Osborne et al36 | 2010 | USA | Single institutional | 20 | No | Breast cancer | PET | 1 | Manual | NA | Microarray | Both | Yes | No | Yes | No | NA |
| Palaskas et al37 | 2011 | USA | Single institutional | 18 | Yes | Breast cancer | PET | 1 | Manual | NA | Microarray, array CGH | Clusters | Yes | Yes | Yes | No | NA |
| Zhu et al38 | 2015 | USA | TCGA and TCIA | 91 | No | Breast cancer | MRI | 38 | Semi-automated | NA | Microarray, array CGH, micro-RNA, somatic mutations | Clusters | Yes | No | No | No | NA |
| Miura et al39 | 2015 | Japan | Single institutional | 77 | No | HCC | MRI | 1 | Manual | Yes | Microarray | Individuals | Yes | No | Yes | Yes | PFS and OS |
| Halle et al40 | 2012 | Norway | Single institutional | 46 | Yes | Cervical cancer | MRI | 1 | Manual | Yes | Microarray | Clusters | Yes | Yes | Yes | Yes | PFS |
CCRCC, clear-cell renal cell carcinoma; CGH, comparative genomic hybridization; GBM, glioblastoma multiforme; HCC, hepatocellular carcinoma; HGG, high-grade glioma; MFS, metastatic-free survival; NA, not available; NSCLC, non-small-cell lung cancer; OS, overall survival; PET, positron emission tomography; PFS, progression-free survival; RFS, recurrence-free survival; TCGA, The Cancer Genome Atlas; TCIA, The Cancer Imaging Archive.